Doctors track Real-World results of new prostate cancer treatment
NCT ID NCT06514521
Summary
This study is observing how well the approved prostate cancer drug Pluvicto works and what side effects patients experience in real-world medical practice in South Korea. It will follow about 278 adult men with advanced prostate cancer that has spread and stopped responding to hormone therapy. Researchers will track side effects and how the cancer responds to treatment, but this is an observational study where patients receive the drug as part of their normal care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Novartis Investigative Site
RECRUITINGSeongnam-si, Gyeonggi-do, 13620, South Korea
-
Novartis Investigative Site
RECRUITINGGyeonggi-do, Korea, 10408, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, Seoul, 06351, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 03722, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 05505, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 06591, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 110-744, South Korea
-
Novartis Investigative Site
RECRUITINGSeoul, 139-706, South Korea
Conditions
Explore the condition pages connected to this study.